• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Medivation, Inc. (MDVN)

    -NasdaqGS
    108.34 Down 0.83(0.76%) Dec 19, 4:00PM EST
    |After Hours : 107.00 Down 1.34 (1.24%) Dec 19, 7:08PM EST
    Add to Portfolio
    Prev Close:109.17
    Open:107.79
    Bid:N/A
    Ask:107.65 x 100
    1y Target Est:114.78
    Beta:0.73
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:107.08 - 111.39
    52wk Range:54.37 - 117.23
    Volume:2,983,821
    Avg Vol (3m):1,140,260
    Market Cap:8.41B
    P/E (ttm):75.08
    EPS (ttm):1.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MDVNDown 0.76%8.41B
    ABTUp 0.61%69.34B
    DNDN 0.00%N/A
    JNJDown 1.18%295.45B

    Key Statistics

    Forward P/E (1 yr):31.49
    P/S (ttm):15.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :2.67
    Quarterly EPS Est (Dec-14) :1.28
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat serious diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback